All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-34877674

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	34877674	A20895T			COVID-19	G S L	View
2	34877674	A28095T			COVID-19	G S L	View
3	34877674	C28087T			COVID-19	G S L	View
4	34877674	C28093T			COVID-19	G S L	View
5	34877674	G28077T			COVID-19	G S L	View
6	34877674	G28881A	N	N	COVID-19	S L	View
7	34877674	G28882A	N	N	COVID-19	S L	View
8	34877674	G28883C	N	N	COVID-19	S L	View
9	34877674	C28706T			COVID-19	S L	View
10	34877674	C28709T			COVID-19	S L	View
11	34877674	C28977T			COVID-19	S L	View
12	34877674	G28704C			COVID-19	S L	View
13	34877674	G28704T			COVID-19	S L	View
14	34877674	G28713A			COVID-19	S L	View
15	34877674	G28714A			COVID-19	S L	View
16	34877674	G28975A			COVID-19	S L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.